​

Ardent Health Partners (ARDT) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ARDT Stock Forecast

Ardent Health Partners (ARDT) stock forecast, based on 11 Wall Street analysts, predicts a 12-month average price target of $15.14, with a high of $19.00 and a low of $12.00. This represents a 70.69% increase from the last price of $8.87.

$5 $8 $11 $14 $17 $20 High: $19 Avg: $15.14 Low: $12 Last Closed Price: $8.87

ARDT Stock Rating

Ardent Health Partners stock's rating consensus is Buy, based on 11 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 7 Buy (63.64%), 3 Hold (27.27%), 1 Sell (9.09%), and 0 Strong Sell (0.00%).

Buy
Total 11 0 1 3 7 Strong Sell Sell Hold Buy Strong Buy

ARDT Price Target Upside V Benchmarks

TypeNameUpside
StockArdent Health Partners70.69%
SectorHealthcare Stocks 15.45%
IndustryMedical Care Facilities Stocks13.25%

Price Target Trends

1M3M12M
# Anlaysts578
Avg Price Target$14.00$15.14$15.88
Last Closing Price$8.87$8.87$8.87
Upside/Downside57.84%70.69%79.03%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 25174-113
Nov, 25282-113
Oct, 25281-112
Sep, 25271-111
Aug, 25271-111
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 18, 2025Mizuho Securities$13.00$8.7049.43%46.56%
Nov 14, 2025Whit MayoLeerink Partners$16.00$9.0177.58%80.38%
Nov 14, 2025Truist Financial$13.00$8.9245.74%46.56%
Nov 14, 2025Ben HendrixRBC Capital$16.00$8.9778.37%80.38%
Nov 14, 2025Morgan Stanley$12.00$9.3029.03%35.29%
Oct 14, 2025Goldman Sachs$19.00$14.1334.47%114.21%
Sep 10, 2025UBS$17.00$13.0330.47%91.66%
Mar 04, 2025RBC Capital$21.00$15.0339.72%136.75%
Oct 10, 2024Matthew GillmorKeyBanc$24.00$18.1232.45%170.57%
Sep 19, 2024Scott FidelStephens$24.00$17.2139.45%170.57%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 17, 2025KeyBancOverweightSector Weightdowngrade
Nov 14, 2025RBC CapitalOutperformOutperformhold
Oct 14, 2025Goldman SachsNeutralinitialise
Sep 10, 2025UBSBuyinitialise
Mar 04, 2025RBC CapitalOutperformOutperformhold
Nov 06, 2024Bank of America SecuritiesNeutraldowngrade
Oct 10, 2024KeyBancOverweightinitialise
Sep 19, 2024StephensOverweightOverweighthold
Aug 16, 2024Loop Capital MarketsBuyBuyhold
Aug 12, 2024CitigroupBuyinitialise

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$0.35$1.59---
Avg Forecast$0.18$1.22$1.99$2.19$2.38
High Forecast$0.18$1.31$2.14$2.46$2.51
Low Forecast$0.18$1.06$1.84$2.05$2.25
Surprise %94.44%30.33%---

Revenue Forecast

$5B $6B $6B $7B $7B $8B Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$5.41B$5.97B---
Avg Forecast$5.63B$5.85B$6.32B$6.68B$7.09B
High Forecast$5.66B$5.86B$6.36B$6.74B$7.15B
Low Forecast$5.59B$5.84B$6.29B$6.60B$7.00B
Surprise %-3.98%1.98%---

Net Income Forecast

$0 $80M $160M $240M $320M $400M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$50.29M$210.34M---
Avg Forecast$25.47M$169.77M$277.05M$314.47M$340.30M
High Forecast$25.68M$187.67M$306.58M$352.43M$359.59M
Low Forecast$25.26M$151.86M$263.60M$293.69M$322.34M
Surprise %97.47%23.90%---

ARDT Forecast FAQ

Is Ardent Health Partners stock a buy?

Ardent Health Partners stock has a consensus rating of Buy, based on 11 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 7 Buy, 3 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Ardent Health Partners is a favorable investment for most analysts.

What is Ardent Health Partners's price target?

Ardent Health Partners's price target, set by 11 Wall Street analysts, averages $15.14 over the next 12 months. The price target range spans from $12 at the low end to $19 at the high end, suggesting a potential 70.69% change from the previous closing price of $8.87.

How does Ardent Health Partners stock forecast compare to its benchmarks?

Ardent Health Partners's stock forecast shows a 70.69% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical care facilities stocks industry (13.25%).

What is the breakdown of analyst ratings for Ardent Health Partners over the past three months?

  • December 2025: 7.69% Strong Buy, 53.85% Buy, 30.77% Hold, 0% Sell, 7.69% Strong Sell.
  • November 2025: 15.38% Strong Buy, 61.54% Buy, 15.38% Hold, 0% Sell, 7.69% Strong Sell.
  • October 2025: 16.67% Strong Buy, 66.67% Buy, 8.33% Hold, 0% Sell, 8.33% Strong Sell.

What is Ardent Health Partners’s EPS forecast?

Ardent Health Partners's average annual EPS forecast for its fiscal year ending in December 2025 is $1.99, marking a 25.16% increase from the reported $1.59 in 2024. Estimates for the following years are $2.19 in 2026, and $2.38 in 2027.

What is Ardent Health Partners’s revenue forecast?

Ardent Health Partners's average annual revenue forecast for its fiscal year ending in December 2025 is $6.32B, reflecting a 5.93% increase from the reported $5.97B in 2024. The forecast for 2026 is $6.68B, and $7.09B for 2027.

What is Ardent Health Partners’s net income forecast?

Ardent Health Partners's net income forecast for the fiscal year ending in December 2025 stands at $277.05M, representing an 31.71% increase from the reported $210.34M in 2024. Projections indicate $314.47M in 2026, and $340.3M in 2027.